FRANKLYN G PRENDERGAST

CIK 1233256 · last filed 2023-10-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$78.81M

Companies

5

Total Filings

27

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMNM Director 60,840 $18.38 $1.12M $0 4 2023-10-04
NeuBase Therapeutics, Inc. (NBSE) Delisted Director $0.38 $0 4 2022-09-12
LTRN Director $3.88 $0 2 2021-11-08
Vyant Bio, Inc. (CGIX) Delisted Director 12,500 $4.61 $57.6K $0 6 2019-08-21
LLY Director 68,574 $1133.00 $77.69M $0 11 2017-11-22

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-10-15 Vyant Bio, Inc. (CGIX) Delisted Grant (A) $0 EDGAR
2012-12-03 LLY Grant (A) +3,083 $145.0K EDGAR
2011-12-01 LLY Grant (A) +3,990 $145.0K EDGAR
2010-12-01 LLY Grant (A) +4,187 $145.0K EDGAR
2009-12-01 LLY Grant (A) +4,040 $145.0K EDGAR
2008-12-02 LLY Grant (A) +4,513 $145.0K EDGAR
2007-12-03 LLY Grant (A) +2,840 $145.0K EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.